Socioeconomic status is an independent predictor of biochemical recurrence among patients with prostate cancer who undergo radical prostatectomy

International Braz J Urol

Volumn 37, Issue 4, 2011, Pages 507-513

  Srougi, Victor ^a   Antunes, Alberto A ^a   Reis, Sabrina T ^a   Dall Oglio, Marcos F ^a   Nesrallah, Adriano J ^a   Leite, Kátia R M ^a   Srougi, Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Neoplasms; Prostate; Prostate specific antigen; Prostatectomy; Socioeconomic factors; Survival

Indexed keywords

EID: 83455172449     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382011000400010     Document Type: Article

References (15)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 2009; 59: 225-49.
2. Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E, et al.: Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007; 110: 2119-52.
3. Adler NE, Newman K: Socioeconomic disparities in health: pathways and policies. Health Aff (Millwood). 2002; 21: 60-76.
4. Cheng I, Witte JS, McClure LA, Shema SJ, Cockburn MG, John EM, et al.: Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California. Cancer Causes Control. 2009; 20: 1431-40.
5. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al.: Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control. 2009; 20: 417-35.
6. Miller DC, Litwin MS, Bergman J, Stepanian S, Connor SE, Kwan L, et al.: Prostate cancer severity among low income, uninsured men. J Urol. 2009; 181: 579-83; discussion 583-4.
7. Greene FL, Page DL, Fleming ID, et al.: AJCC Cancer Staging Manual, 6th edn. New York: Springer-Verlag, 2002; pp. 3-15.
8. Gleason DF: Histologic grading and clinical staging of prostatic carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (ed.), Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, IARC Press. 2004: pp. 167-214.
9. Brasil: Ministério do Planejamento, Orçamento e Gestão. Instituto Brasileiro de Geografia e Estatística [internet]. (cited april. 2009). Available from: http://www.ibge.gov.br.
10. Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, et al.: Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. J Urol. 2000; 163: 1171-7.
11. Obek C, Sadek S, Lai S, Civantos F, Rubinowicz D, Soloway MS: Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. Urology. 1999; 54: 682-8.
12. Kato RB, Srougi V, Salvadori FA, Ayres PP, Leite KM, Srougi M: Pretreatment tumor volume estimation based on total serum psa in patients with localized prostate cancer. Clinics (Sao Paulo). 2008; 63: 759-62.
13. Godley PA, Schenck AP, Amamoo MA, Schoenbach VJ, Peacock S, Manning M, et al.: Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst. 2003; 95: 1702-10.
14. Gilligan T: Social disparities and prostate cancer: mapping the gaps in our knowledge. Cancer Causes Control. 2005; 16: 45-53.
15. Tewari AK, Gold HT, Demers RY, Johnson CC, Yadav R, Wagner EH, et al.: Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology. 2009; 73: 624-30. Erratum in: Urology. 2009; 74: 239. Yood, Marianne Ulcickas [added].